BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8193521)

  • 1. Hypertension and coronary heart disease risk factor management.
    Houston MC
    Clin Auton Res; 1993 Dec; 3(6):357-61. PubMed ID: 8193521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension and coronary heart disease risk factor management.
    Houston MC
    Aust Fam Physician; 1994 Feb; 23(2):243-5, 248-51. PubMed ID: 8161313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights and new approaches for the treatment of essential hypertension: selection of therapy based on coronary heart disease risk factor analysis, hemodynamic profiles, quality of life, and subsets of hypertension.
    Houston MC
    Am Heart J; 1989 Apr; 117(4):911-51. PubMed ID: 2648781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of hypertension and associated risk factors for the prevention of long-term cardiac complications.
    Houston MC
    J Cardiovasc Pharmacol; 1993; 21 Suppl 2():S2-13. PubMed ID: 7692147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights and approaches to reduce end-organ damage in the treatment of hypertension: subsets of hypertension approach.
    Houston MC
    Am Heart J; 1992 May; 123(5):1337-67. PubMed ID: 1575152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension strategies for therapeutic intervention and prevention of end-organ damage.
    Houston MC
    Prim Care; 1991 Sep; 18(3):713-53. PubMed ID: 1946795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Beta-Blockers in the Treatment of Hypertension.
    Cruickshank JM
    Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of the primary prevention trials against coronary heart disease.
    Kannel WB
    J Hypertens Suppl; 1990 Dec; 8(7):S245-50. PubMed ID: 1982770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Goals of antihypertensive therapy.
    McVeigh GE; Flack J; Grimm R
    Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive therapy: new strategies beyond blood pressure control.
    Stumpe KO
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S1-4. PubMed ID: 1283182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New therapeutic outlooks in the treatment of the hypertensive patient].
    Ambrosioni E; Bacchelli S; Borghi C
    Ann Ital Med Int; 1995 Oct; 10 Suppl():78S-81S. PubMed ID: 8562273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive therapy in diabetic patients.
    Weidmann P; Boehlen LM; de Courten M; Ferrari P
    J Hum Hypertens; 1992 Dec; 6 Suppl 2():S23-36. PubMed ID: 1289510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical considerations and results with the combination of verapamil and trandolapril: blood pressure reduction and beyond.
    Kirchengast M
    J Hypertens Suppl; 1997 Mar; 15(2):S27-33. PubMed ID: 9218195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk-benefit aspects of antihypertensive drugs.
    Holzgreve H; Middeke M
    Drugs; 1992; 44 Suppl 1():67-73. PubMed ID: 1283587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2010 guidelines of the Taiwan Society of Cardiology for the management of hypertension.
    Chiang CE; Wang TD; Li YH; Lin TH; Chien KL; Yeh HI; Shyu KG; Tsai WC; Chao TH; Hwang JJ; Chiang FT; Chen JH;
    J Formos Med Assoc; 2010 Oct; 109(10):740-73. PubMed ID: 20970072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.